Exploiting signaling rewiring in cancer cells with co‐existing oncogenic drivers
The development of tailored therapies designed to specifically target driver oncogenes has initiated a revolutionary era in cancer biology. The availability of a growing number of selective inhibitors has generated novel experimental and clinical paradigms. These represent an opportunity and a chall...
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Wiley
2023-11-01
|
| سلاسل: | Molecular Oncology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/1878-0261.13547 |